Drreddys Laboratories | RDY - Current Assets


Drreddys Laboratories reported INR3.31B in Current Assets for its fiscal quarter ending in December of 2025.





Current Assets Change Date
ANI Pharmaceuticals USD 698.4M 95.77M Sep/2025
Aurora Cannabis CAD 423.84M 41.46M Sep/2025
Bayer EUR 32.88B 873M Sep/2025
Canopy Growth CAD 445.82M 142.46M Sep/2025
Cipla INR 249.18B 16.3B Sep/2025
Corcept Therapeutics USD 541.13M 98.02M Sep/2025
Drreddys Laboratories INR 3.31B 164.26M Dec/2025
GlaxoSmithKline GBP 17.84B 169M Sep/2025
Hikma Pharmaceutical USD 2.56B 294M Jun/2025
Lonza CHF 5.44B 113M Dec/2024
Novartis USD 28.2B 2.26B Sep/2025
Pacira USD 562.75M 182.86M Sep/2025
Prestige Brands USD 497.41M 16.89M Sep/2025
Richter Gedeon HUF 732.92B 91.86B Sep/2025
Sun Pharmaceuticals INR 601.36B 75.42B Sep/2025
Supernus Pharmaceuticals USD 593.89M 144.98M Sep/2025
Teva Pharmaceutical Industries USD 13.95B 1.21B Dec/2025